vs

Side-by-side financial comparison of Stoke Therapeutics, Inc. (STOK) and VERRA MOBILITY Corp (VRRM). Click either name above to swap in a different company.

VERRA MOBILITY Corp is the larger business by last-quarter revenue ($257.9M vs $158.6M, roughly 1.6× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 7.3%, a 63.9% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 16.4%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $5.7M).

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

Verra Mobility Corp is a leading global smart mobility technology solution provider. It delivers toll management, parking and traffic compliance enforcement, connected vehicle services, and fleet management tools, serving government transport agencies, rental car operators, commercial fleet owners, and automotive partners across North America, Europe, and Asia-Pacific.

STOK vs VRRM — Head-to-Head

Bigger by revenue
VRRM
VRRM
1.6× larger
VRRM
$257.9M
$158.6M
STOK
Growing faster (revenue YoY)
STOK
STOK
+3644.7% gap
STOK
3661.1%
16.4%
VRRM
Higher net margin
STOK
STOK
63.9% more per $
STOK
71.2%
7.3%
VRRM
More free cash flow
STOK
STOK
$125.9M more FCF
STOK
$131.7M
$5.7M
VRRM

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
STOK
STOK
VRRM
VRRM
Revenue
$158.6M
$257.9M
Net Profit
$112.9M
$18.9M
Gross Margin
Operating Margin
70.2%
16.7%
Net Margin
71.2%
7.3%
Revenue YoY
3661.1%
16.4%
Net Profit YoY
528.0%
128.3%
EPS (diluted)
$1.90
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STOK
STOK
VRRM
VRRM
Q4 25
$257.9M
Q3 25
$261.9M
Q2 25
$236.0M
Q1 25
$158.6M
$223.3M
Q4 24
$22.6M
$221.5M
Q3 24
$225.6M
Q2 24
$222.4M
Q1 24
$209.7M
Net Profit
STOK
STOK
VRRM
VRRM
Q4 25
$18.9M
Q3 25
$46.8M
Q2 25
$38.6M
Q1 25
$112.9M
$32.3M
Q4 24
$-10.5M
$-66.7M
Q3 24
$34.7M
Q2 24
$34.2M
Q1 24
$29.1M
Operating Margin
STOK
STOK
VRRM
VRRM
Q4 25
16.7%
Q3 25
28.6%
Q2 25
26.8%
Q1 25
70.2%
25.7%
Q4 24
-60.4%
-19.6%
Q3 24
28.3%
Q2 24
27.5%
Q1 24
25.9%
Net Margin
STOK
STOK
VRRM
VRRM
Q4 25
7.3%
Q3 25
17.9%
Q2 25
16.3%
Q1 25
71.2%
14.5%
Q4 24
-46.4%
-30.1%
Q3 24
15.4%
Q2 24
15.4%
Q1 24
13.9%
EPS (diluted)
STOK
STOK
VRRM
VRRM
Q4 25
$0.12
Q3 25
$0.29
Q2 25
$0.24
Q1 25
$1.90
$0.20
Q4 24
$-0.15
$-0.39
Q3 24
$0.21
Q2 24
$0.20
Q1 24
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STOK
STOK
VRRM
VRRM
Cash + ST InvestmentsLiquidity on hand
$274.8M
$65.3M
Total DebtLower is stronger
$1.0B
Stockholders' EquityBook value
$350.1M
$293.0M
Total Assets
$406.9M
$1.6B
Debt / EquityLower = less leverage
3.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STOK
STOK
VRRM
VRRM
Q4 25
$65.3M
Q3 25
$196.1M
Q2 25
$147.7M
Q1 25
$274.8M
$108.5M
Q4 24
$128.0M
$77.6M
Q3 24
$206.1M
Q2 24
$122.0M
Q1 24
$149.5M
Total Debt
STOK
STOK
VRRM
VRRM
Q4 25
$1.0B
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Q1 24
$1.0B
Stockholders' Equity
STOK
STOK
VRRM
VRRM
Q4 25
$293.0M
Q3 25
$403.1M
Q2 25
$352.1M
Q1 25
$350.1M
$299.6M
Q4 24
$229.0M
$265.1M
Q3 24
$486.5M
Q2 24
$438.6M
Q1 24
$449.0M
Total Assets
STOK
STOK
VRRM
VRRM
Q4 25
$1.6B
Q3 25
$1.8B
Q2 25
$1.7B
Q1 25
$406.9M
$1.6B
Q4 24
$271.6M
$1.6B
Q3 24
$1.9B
Q2 24
$1.8B
Q1 24
$1.8B
Debt / Equity
STOK
STOK
VRRM
VRRM
Q4 25
3.51×
Q3 25
2.55×
Q2 25
2.93×
Q1 25
3.45×
Q4 24
3.90×
Q3 24
2.13×
Q2 24
2.36×
Q1 24
2.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STOK
STOK
VRRM
VRRM
Operating Cash FlowLast quarter
$131.8M
$40.0M
Free Cash FlowOCF − Capex
$131.7M
$5.7M
FCF MarginFCF / Revenue
83.0%
2.2%
Capex IntensityCapex / Revenue
0.1%
13.3%
Cash ConversionOCF / Net Profit
1.17×
2.12×
TTM Free Cash FlowTrailing 4 quarters
$136.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STOK
STOK
VRRM
VRRM
Q4 25
$40.0M
Q3 25
$77.7M
Q2 25
$75.1M
Q1 25
$131.8M
$63.0M
Q4 24
$-23.2M
$40.5M
Q3 24
$108.8M
Q2 24
$40.0M
Q1 24
$34.3M
Free Cash Flow
STOK
STOK
VRRM
VRRM
Q4 25
$5.7M
Q3 25
$49.0M
Q2 25
$40.3M
Q1 25
$131.7M
$41.7M
Q4 24
$-23.2M
$21.6M
Q3 24
$85.1M
Q2 24
$26.0M
Q1 24
$20.1M
FCF Margin
STOK
STOK
VRRM
VRRM
Q4 25
2.2%
Q3 25
18.7%
Q2 25
17.1%
Q1 25
83.0%
18.7%
Q4 24
-102.7%
9.8%
Q3 24
37.7%
Q2 24
11.7%
Q1 24
9.6%
Capex Intensity
STOK
STOK
VRRM
VRRM
Q4 25
13.3%
Q3 25
11.0%
Q2 25
14.8%
Q1 25
0.1%
9.5%
Q4 24
0.2%
8.5%
Q3 24
10.5%
Q2 24
6.3%
Q1 24
6.8%
Cash Conversion
STOK
STOK
VRRM
VRRM
Q4 25
2.12×
Q3 25
1.66×
Q2 25
1.95×
Q1 25
1.17×
1.95×
Q4 24
Q3 24
3.13×
Q2 24
1.17×
Q1 24
1.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STOK
STOK

Segment breakdown not available.

VRRM
VRRM

Services$239.5M93%
CA$8.4M3%
GB$5.7M2%
Other Customer$1.6M1%
Parking Solutions$1.1M0%

Related Comparisons